Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.

Ryan C Miller,Andrew Song,Ayesha Ali,Voichita Bar-Ad,Nina L. Martinez,Jon Glass,Iyad Alnahhas,David W. Andrews,Kevin Judy,James J. Evans,Christopher J. Farrell,Maria Werner-Wasik,Inna Chervoneva,Michele Ly,Joshua D. Palmer,Haisong Liu,Wenyin Shi

Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.

2021

Ryan C Miller
Andrew Song
Ayesha Ali
Voichita Bar-Ad
Nina L. Martinez
Jon Glass
Iyad Alnahhas
David W. Andrews
Kevin Judy
James J. Evans
Christopher J. Farrell
Maria Werner-Wasik
Inna Chervoneva
Michele Ly
Joshua D. Palmer
Haisong Liu
Wenyin Shi

2056Background: Standard of care for patients with newly diagnosed glioblastoma includes concurrent chemoradiation and maintenance temozolomide with Tumor Treating Fields (TTFields). Preclinical st...

Keywords:

Glioblastoma
Radiology
standard of care
Medicine
Temozolomide
Scalp
newly diagnosed
concurrent chemoradiation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations